0000899243-20-020430.txt : 20200724 0000899243-20-020430.hdr.sgml : 20200724 20200724190305 ACCESSION NUMBER: 0000899243-20-020430 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200722 FILED AS OF DATE: 20200724 DATE AS OF CHANGE: 20200724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CROCKER GARY L CENTRAL INDEX KEY: 0001094201 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35409 FILM NUMBER: 201047861 MAIL ADDRESS: STREET 1: MERRIMACK PHARMACEUTICALS, INC. STREET 2: ONE KENDALL SQUARE, SUITE B7201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERRIMACK PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001274792 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-441-1000 MAIL ADDRESS: STREET 1: ONE BROADWAY STREET 2: 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-07-22 0 0001274792 MERRIMACK PHARMACEUTICALS INC MACK 0001094201 CROCKER GARY L C/O MERRIMACK PHARMACEUTICALS, INC. ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 1 1 0 0 See Remarks Common Stock 2020-07-22 4 S 0 17000 3.202 D 0 D Common Stock 2020-07-22 4 S 0 5986 3.0419 D 0 D Common Stock 2020-07-22 4 S 0 8428 3.202 D 0 D Common Stock 2020-07-22 4 S 0 86549 3.0419 D 0 D Common Stock 2020-07-22 4 S 0 52068 3.0419 D 0 I See Footnote Common Stock 2020-07-22 4 S 0 17250 3.202 D 0 I See Footnote Common Stock 2020-07-22 4 S 0 6228 3.202 D 0 I See Footnote Shares held directly by Reporting Person. Shares held jointly with Reporting Person's wife. Shares held directly by Reporting Person's wife. Shares held by Crocker Family Investments, LLC, over which Reporting Person is the Managing Member. Shares held by Crocker Ventures, LLC, over which Reporting Person is the President and Managing Member. The sale of the securities referenced in this From 4 were conducted in a private transaction between Gary Crocker and certain family members and affiliates as the sellers and each of Western Standard Partners, L.P., Western Standard Partners QP, L.P., Newtyn Partners, LP, and Newton Partners TE, LP as the purchasers, regarding all shares of the Company over which he had dispositive control, along with the record owners of most of the shares of the Company over which Reporting Person had voting control. The purpose of the sale was to minimize tax liability by matching losses from these sales of Company stock with other investment gains. Gary Crocker is President and Chairman of Merrimack Pharmaceuticals, Inc. (the "Company"). Eric Andersen, a member of the Company's Board of Directors, is Managing Member of Western Standard LLC, the investment manager for each of Western Standard Partners L.P. and Western Standard Partners QP L.P. (continued from footnote 6) Noah Levy, a member of the Company's Board of Directors, is Managing Member of Newtyn Management, LLC, the investment manager for Newtyn Partners, LP, and Newton Partners TE, LP. In addition to the sale of securities referenced in Table I of this Form 4, 161,039 shares held by certain trusts established for members of Reporting Person's family, certain entities controlled by members of his family and certain individual members of his family, and in which Reporting Person has no pecuniary interest, were also sold to the purchasers (111,453 shares at a price of $3.2020 per share, and 49,586 shares at a price of $3.0419 per share). Such holders were parties to a Shareholder Voting Agreement dated December 20, 2010, pursuant to which the parties to the agreement had agreed to vote his, her or its shares as directed by Crocker Ventures, LLC. Reporting Person is the President and Managing Member of Crocker Ventures, LLC and in connection therewith shared voting control over all the shares subject to the Shareholder Voting Agreement. In connection with the disposition of shares disclosed herein, the Shareholder Voting Agreement has been terminated and thus the Reporting Person no longer shares voting control of any shares held by third parties. /s/ Gary L. Crocker 2020-07-24